PT1524967E - Preparação farmacêutica contendo um composto de benzimidazole misturado com celulose microcristalina e método para a sua preparação. - Google Patents

Preparação farmacêutica contendo um composto de benzimidazole misturado com celulose microcristalina e método para a sua preparação. Download PDF

Info

Publication number
PT1524967E
PT1524967E PT03738123T PT03738123T PT1524967E PT 1524967 E PT1524967 E PT 1524967E PT 03738123 T PT03738123 T PT 03738123T PT 03738123 T PT03738123 T PT 03738123T PT 1524967 E PT1524967 E PT 1524967E
Authority
PT
Portugal
Prior art keywords
microcrystalline cellulose
benzimidazole compound
preparation
compound mixed
pharmaceutical preparation
Prior art date
Application number
PT03738123T
Other languages
English (en)
Inventor
Frank Muskulus
Peter Kraass
Andrea Burgenmeister
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10235475A external-priority patent/DE10235475B4/de
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of PT1524967E publication Critical patent/PT1524967E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT03738123T 2002-08-02 2003-07-16 Preparação farmacêutica contendo um composto de benzimidazole misturado com celulose microcristalina e método para a sua preparação. PT1524967E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40007102P 2002-08-02 2002-08-02
DE10235475A DE10235475B4 (de) 2002-08-02 2002-08-02 Arzneimittel mit einer Benzimidazolverbindung im Gemisch mit mikrokristalliner Cellulose und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
PT1524967E true PT1524967E (pt) 2008-04-03

Family

ID=31716591

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03738123T PT1524967E (pt) 2002-08-02 2003-07-16 Preparação farmacêutica contendo um composto de benzimidazole misturado com celulose microcristalina e método para a sua preparação.

Country Status (16)

Country Link
US (1) US7732474B2 (pt)
EP (1) EP1524967B1 (pt)
JP (1) JP2005536527A (pt)
AT (1) ATE388695T1 (pt)
AU (1) AU2003244647B2 (pt)
BR (1) BR0313173A (pt)
CA (1) CA2494716A1 (pt)
DE (1) DE60319707T2 (pt)
ES (1) ES2299710T3 (pt)
HK (1) HK1072195A1 (pt)
NO (1) NO20051018L (pt)
PL (1) PL208130B1 (pt)
PT (1) PT1524967E (pt)
RU (1) RU2332237C2 (pt)
WO (1) WO2004014345A1 (pt)
ZA (1) ZA200500324B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130602A0 (en) 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
JP2007526319A (ja) * 2004-03-03 2007-09-13 テバ ファーマシューティカル インダストリーズ リミティド 酸不安定性薬物を含んでなる安定な医薬組成物
WO2006026829A1 (en) * 2004-09-09 2006-03-16 Metelli Pty Ltd Stable paste composition of enteric coated acid labile active agent and use thereof
EP1785135A1 (en) * 2005-11-10 2007-05-16 Laboratorios Del Dr. Esteve, S.A. New stabilized galenic formulations comprising lansoprazole and their preparation
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
CN101500541B (zh) * 2006-08-11 2011-06-15 旭化成化学株式会社 含有水难溶性药物的球状素颗粒的制造方法
US8911787B2 (en) * 2008-02-26 2014-12-16 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
EP2319504A1 (en) * 2009-11-07 2011-05-11 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical solid dosage form
WO2012171540A1 (en) * 2011-06-15 2012-12-20 Bene-Arzneimittel Gmbh Suppository comprising pantoprazole comprised in pellets with a cellulose core
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017061621A1 (ja) * 2015-10-07 2017-04-13 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3292862A1 (en) 2016-09-07 2018-03-14 Sandoz Ag Omeprazole formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
JPH0733659A (ja) * 1992-07-17 1995-02-03 Yoshitomi Pharmaceut Ind Ltd 抗潰瘍剤含有製剤
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
DE29522419U1 (de) * 1994-07-08 2003-07-03 AstraZeneca AB, Södertälje Tablettierte Mehrfacheinheits-Dosisform
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) * 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
DE19626045C2 (de) 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
CZ291842B6 (cs) * 1997-03-13 2003-06-18 Hexal Ag Farmaceutická formulace
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6228400B1 (en) 1999-09-28 2001-05-08 Carlsbad Technology, Inc. Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
DE19959419A1 (de) * 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
ATE297194T1 (de) * 1999-12-16 2005-06-15 Medinfar Produtos Farmaceutico Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate

Also Published As

Publication number Publication date
PL208130B1 (pl) 2011-03-31
PL374827A1 (en) 2005-10-31
BR0313173A (pt) 2007-07-17
ES2299710T3 (es) 2008-06-01
WO2004014345A1 (en) 2004-02-19
US20050129760A1 (en) 2005-06-16
ATE388695T1 (de) 2008-03-15
EP1524967A1 (en) 2005-04-27
HK1072195A1 (en) 2005-08-19
US7732474B2 (en) 2010-06-08
RU2005102814A (ru) 2005-12-20
AU2003244647B2 (en) 2008-04-17
DE60319707T2 (de) 2008-07-17
JP2005536527A (ja) 2005-12-02
CA2494716A1 (en) 2004-02-19
RU2332237C2 (ru) 2008-08-27
AU2003244647A1 (en) 2004-02-25
EP1524967B1 (en) 2008-03-12
ZA200500324B (en) 2006-07-26
DE60319707D1 (de) 2008-04-24
NO20051018L (no) 2005-02-24

Similar Documents

Publication Publication Date Title
HK1072195A1 (en) Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline celluloseand a method for its preparation
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
NZ597260A (en) Formulations for parenteral delivery of compounds and uses thereof comprising methylnaltrexone
SG151331A1 (en) Crystalline polymorph of a bazedoxifene acetate
WO2003103603A3 (en) NEW FORMIATE-TYPE SALT OF O-DESMETHYLVENLAFAXINE
TW200510375A (en) New compounds
RS52233B (en) THE PHARMACEUTICAL DOSAGE FORM CONTAINING GRANULES AND ITS PRODUCTION PROCEDURE
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
RS90904A (en) Novel perindopril salt and pharmaceutical compositions containing same
TR201907729T4 (tr) Bir anti-çekirdekleştirici ajan içeren farmasötik bileşim.
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
UA122762C2 (uk) Пероральна композиція 9-[(2,2-диметилпропіламіно)-метил]-міноцикліну або його солі, тверда пресована дозована форма, композиція для ін'єкцій, застосування та спосіб приготування фармацевтичної композиції
HK1129571A1 (en) Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia tpo
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim
EP1735005A4 (en) PROCESS FOR ENCAPSULATING ORAL INGESTION MATERIALS TO MODIFY THE DIGESTION SITE, THE SITE OF ACTION OR STABILITY
IL165220A0 (en) Novel compounds, their use and preparation
MY135460A (en) Method of stimulating hair growth using benzopyrans
MXPA05009686A (es) Composicion farmaceutica comprendiendo acido 5-metil-2-(2'-cloro-6'-fluoroanilino) fenilacetico.
UA81664C2 (ru) Производные дифенилмочевины и их применение, как блокаторов хлоридных каналов
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.
WO2004014318A3 (en) Levothyroxine compositions and methods
EA200970097A1 (ru) Фармацевтическая композиция, содержащая бикалутамид, и способ её применения
PL1668003T3 (pl) Benzoizoksazole
UA61543C2 (en) A METHOD FOR THE PREPARATION OF COMPLEX COMPOUND OF PLATINUM (II) 3 n-DNA
RS20060104A (en) Delta 15-d-homosteroids having an androgenic effect